Zavada; Jan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Zavada; Jan.The latest application filed is for "mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use".
Company Profile
1.23.27
- Zavada; Jan - Prague CZ
- Zavada; Jan - Praque CZ
- Zavada; Jan - Bratislava CS
Patent Activity
| Patent | Date |
|---|---|
| Mn/ca Ix-specific Monoclonal Antibodies Generated From Mn/ca Ix-deficient Mice And Methods Of Use App 20150266971 - Pastorek; Jaromir ; et al. | 2015-09-24 |
| MN gene and protein Grant 8,759,493 - Zavada , et al. June 24, 2 | 2014-06-24 |
| MN Gene and Protein App 20110319599 - Zavada; Jan ; et al. | 2011-12-29 |
| MN Gene and Protein App 20110244475 - Zavada; Jan ; et al. | 2011-10-06 |
| MN gene and protein Grant 8,012,707 - Zavada , et al. September 6, 2 | 2011-09-06 |
| MN/CA IX and cancer prognosis Grant 7,993,852 - Ebert , et al. August 9, 2 | 2011-08-09 |
| MN gene and protein Grant 7,910,691 - Zavada , et al. March 22, 2 | 2011-03-22 |
| Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes Grant 7,846,673 - Pastorek , et al. December 7, 2 | 2010-12-07 |
| MN Gene and Protein App 20100297752 - Zavada; Jan ; et al. | 2010-11-25 |
| Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes Grant 7,833,728 - Pastorek , et al. November 16, 2 | 2010-11-16 |
| MN/CA IX and Cancer Prognosis App 20100267040 - Ebert; Matthias ; et al. | 2010-10-21 |
| Soluble form of carbonic anhydrase IX (S-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/NEU/C-ERBB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes Grant 7,816,493 - Pastorek , et al. October 19, 2 | 2010-10-19 |
| MN gene and protein Grant 7,816,496 - Zavada , et al. October 19, 2 | 2010-10-19 |
| MN Gene and Protein App 20100172837 - Zavada; Jan ; et al. | 2010-07-08 |
| MN/CA IX and cancer prognosis Grant 7,741,048 - Ebert , et al. June 22, 2 | 2010-06-22 |
| MN gene and protein Grant 7,713,704 - Zavada , et al. May 11, 2 | 2010-05-11 |
| MN Gene and Protein App 20100080815 - Zavada; Jan ; et al. | 2010-04-01 |
| MN/CA IX and Cancer Prognosis App 20090176240 - Ebert; Matthias ; et al. | 2009-07-09 |
| MN Gene and Protein App 20090118473 - Zavada; Jan ; et al. | 2009-05-07 |
| MN/CA IX and cancer prognosis Grant 7,524,634 - Ebert , et al. April 28, 2 | 2009-04-28 |
| MN Gene and Protein App 20080221309 - Zavada; Jan ; et al. | 2008-09-11 |
| MN Gene and Protein App 20080214787 - Zavada; Jan ; et al. | 2008-09-04 |
| MN Gene and Protein App 20080199881 - Zavada; Jan ; et al. | 2008-08-21 |
| MN Gene and Protein App 20080193951 - Zavada; Jan ; et al. | 2008-08-14 |
| Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IX's Coexpression with HER-2/neu/c-erbB-2, and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes App 20080176258 - Pastorek; Jaromir ; et al. | 2008-07-24 |
| Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IX's Coexpression with HER-2/neu/c-erbB-2, and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes App 20080176310 - Pastorek; Jaromir ; et al. | 2008-07-24 |
| MN Gene and Protein App 20080176268 - Zavada; Jan ; et al. | 2008-07-24 |
| Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IX's Coexpression with Her-2/neu/c-erbB-2, and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes App 20080177046 - Pastorek; Jaromir ; et al. | 2008-07-24 |
| MN Gene and Protein App 20080146780 - Zavada; Jan ; et al. | 2008-06-19 |
| MN gene and protein App 20070255043 - Zavada; Jan ; et al. | 2007-11-01 |
| MN gene and protein Grant 7,186,514 - Zavada , et al. March 6, 2 | 2007-03-06 |
| Mn/ca ix and cancer prognosis App 20070042376 - Ebert; Matthias ; et al. | 2007-02-22 |
| MN gene and protein App 20060235203 - Zavada; Jan ; et al. | 2006-10-19 |
| Anti-idiotype antibodies to MN proteins and MN polypeptides Grant 7,115,715 - Zavada , et al. October 3, 2 | 2006-10-03 |
| Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes App 20050031623 - Pastorek, Jaromir ; et al. | 2005-02-10 |
| MN gene and protein App 20050003425 - Zavada, Jan ; et al. | 2005-01-06 |
| MN gene and protein App 20040259126 - Zavada, Jan ; et al. | 2004-12-23 |
| MN gene and protein Grant 6,774,117 - Zavada , et al. August 10, 2 | 2004-08-10 |
| MN gene and protein Grant 6,770,438 - Zavada , et al. August 3, 2 | 2004-08-03 |
| MN gene and protein App 20030049828 - Zavada, Jan ; et al. | 2003-03-13 |
| MN gene and protein App 20020137910 - Zavada, Jan ; et al. | 2002-09-26 |
| MN gene and protein Grant 6,297,041 - Zavada , et al. October 2, 2 | 2001-10-02 |
| MN gene and protein Grant 6,297,051 - Zavada , et al. October 2, 2 | 2001-10-02 |
| MN gene and protein Grant 6,069,242 - Zavada , et al. May 30, 2 | 2000-05-30 |
| MN gene and protein Grant 6,027,887 - Zavada , et al. February 22, 2 | 2000-02-22 |
| Methods of imaging neoplastic disease and of detecting and quantifying MN protein/polypeptide using MN-specific antibodies Grant 6,004,535 - Zavada , et al. December 21, 1 | 1999-12-21 |
| Immunological methods of detecting MN proteins and MN polypeptides Grant 5,989,838 - Zavada , et al. November 23, 1 | 1999-11-23 |
| MN gene and protein Grant 5,387,676 - Zavada , et al. February 7, 1 | 1995-02-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 